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OBJECTIVES This study was designed to examine the impact of repeated intravascular ultrasound (IVUS)
examinations on transplant coronary artery disease (CAD).
BACKGROUND Serial IVUS is the most accurate method for early detection and surveillance of transplant
CAD. However, the long-term safety of serial IVUS exams is not well described. Accord-
ingly, we examined the impact of repeated IVUS examinations on transplant CAD.
METHODS We examined 226 transplant recipients who underwent one or more IVUS examinations and
coronary angiography at least one year after the last IVUS exam. The coronary angiograms
were analyzed using quantitative coronary angiography. Vessel diameters, frequency, and
severity of stenoses in IVUS-imaged and nonimaged coronary arteries were compared. In a
subgroup analysis of 31 patients, angiographic lumen diameters were measured at baseline
(within eight weeks of transplantation) and during follow-up (after two, three, or four IVUS
studies).
RESULTS In the 226 patients, 548 coronary arteries were previously imaged by IVUS and 130 arteries
were not imaged by IVUS. On subsequent angiograms, stenoses were observed in 16.2%
(21/130) of nonimaged arteries and 19.5% (107/548) of imaged arteries (p  0.38). The
arterial diameters of nonimaged and imaged arteries were not significantly different (p 
0.07), regardless of the number of IVUS exams and duration of follow-up. Subgroup analysis
revealed a significant decrease in vessel lumen diameter over time in nonimaged as well as
imaged arteries. The magnitude of the diameter decrease was not significantly different
between the two groups.
CONCLUSIONS Repeated IVUS examinations following heart transplantation do not result in angiographi-
cally evident acceleration of transplant CAD. Therefore, serial IVUS imaging is a safe method
for the detection and surveillance of transplant CAD. (J Am Coll Cardiol 2003;41:
1739–43) © 2003 by the American College of Cardiology Foundation
Intravascular ultrasound (IVUS) is a complementary tech-
nique to coronary angiography for assessing the presence,
extent, and progression of coronary atherosclerosis. The
value of IVUS in the early detection and surveillance of
transplant coronary artery disease (CAD) has been shown
by numerous studies (1–5). On the basis of these studies,
many transplant centers have performed serial IVUS exam-
inations to assess the progression of transplant CAD. More
recently, serial IVUS analysis of plaque burden has been
utilized as an end point in pharmacologic atherosclerosis
regression and progression studies (6).
However, there is concern that repeated intracoronary
instrumentation itself might accelerate CAD by causing
endothelial injury. Data demonstrating the long-term safety
of repeated IVUS imaging are limited. In this study, we
sought to assess the effect of repeated IVUS examinations
on the progression of coronary lesions in cardiac transplant
patients.
METHODS
The study group consisted of all patients who underwent
cardiac transplantation at our institution between 1992 and
2001. Patients who were not eligible for cardiac catheter-
ization, who died during hospitalization, or who could not
provide informed consent were excluded. The study proto-
col was approved by our Institutional Review Board. In this
study, we included all patients who underwent at least one
IVUS study and had follow-up coronary angiography within
two years after the last IVUS exam. The coronary angio-
grams of these patients were analyzed by quantitative
coronary angiography (QCA).
IVUS protocol. Intravascular ultrasound was performed at
baseline (within eight weeks of transplantation) and at the
time of the annual surveillance coronary angiography fol-
lowing standard protocols (7). After administration of
heparin and intracoronary nitroglycerin, a 30-MHz, 3.5F
monorail ultrasound catheter (Boston Scientific, Maple
Grove, Minnesota) interfaced with a dedicated scanner
(Hewlett-Packard, Andover, Massachusetts) was intro-
duced over a 0.014-inch angioplasty guide wire. The trans-
ducer was advanced to a distal site in the coronary artery
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large enough to avoid flow interruption, and the location
was documented by cineangiography. During a slow distal
to proximal pullback, ultrasound images were recorded on a
SVHS tape.
Coronary angiography. Using standard technique, a 6F or
7F sheath was placed in the femoral artery and selective cine
left and right coronary angiography was performed using
manual injections of contrast. Standard projections of the
left anterior descending artery (LAD), left circumflex artery
(LCX), and right coronary artery (RCA) were obtained.
QCA. Quantitative coronary angiography was performed
on digitized coronary angiograms obtained within two years
after the last IVUS exam and evaluated using the CAAS II
software (Cardiovascular Angiographic Analysis System
version 5vl. x, 1996; Pie Medical Imaging, Maastricht, Neth-
erlands). For each artery, the best single-plane angiographic
projection was selected. Vessel lumen diameters and stenosis
severity were measured for all three epicardial arteries.
For the assessment of the arterial lumen diameter, each
artery was divided into proximal, middle, and distal Coro-
nary Artery Surgery Study (CASS) segments (8). After
calibration of the angiography catheter, a line was tracked
through the center of the entire length of the vessel
segment. The CAAS software then calculated the lumen
diameters using the edge detection system. For each seg-
ment the maximum and minimum diameter in an angio-
graphically normal site was recorded and an average diam-
eter calculated (9).
For the assessment of stenosis severity, all angiographi-
cally visible lesions were included. To quantify the severity
of the lesion, the minimal lumen diameter and the diameter
in an uninvolved reference site were measured and the
percent stenosis calculated. The vessel lumen diameters and
stenosis severity of arteries subjected to IVUS interrogation
were compared with vessels never imaged by IVUS.
Comparison between baseline and follow-up coronary
angiograms. In a subset of patients, the largest proximal
and smallest distal vessel lumen diameters were compared at
baseline and follow-up. The baseline angiogram was per-
formed within eight weeks of transplantation and the
follow-up angiograms after two, three, or four IVUS stud-
ies. The diameter measurements at baseline and follow-up
were performed at the same coronary artery measurement
sites in matched projection planes. Baseline and follow-up
diameter measurements were compared to identify any
change over time. Changes were further compared among
arteries subjected to IVUS imaging and those that were
never imaged by IVUS.
Statistical analysis. Statistical analysis was performed us-
ing SAS software (SAS Institute Inc., release 8.2, Cary,
North Carolina). Analysis of the lumen diameter and
stenoses measurements was performed using mixed models
for spatial repeated measures. This method takes into
account the measurement of the same parameters at differ-
ent spatial sites. The stenoses data were rank-transformed
before analysis, because the stenoses were not normally
distributed. The chi-square test was used to evaluate the
stenosis frequency. Levels of significance were determined,
and differences were considered significant if p  0.05.
RESULTS
At our institution, 380 patients underwent at least one
IVUS exam following cardiac transplantation. Of these, 102
patients did not follow up at our institution, had expired, or
had a recent cardiac transplantation and, thus, had not yet
received a follow-up angiogram. Of the remaining 278
patients, angiograms suitable for QCA were available in 226
patients.
Of these 226 patients, 81% were men and 19% women. A
total of 678 vessels were analyzed. Of these, 548 vessels
underwent one to six IVUS exams and 130 vessels were
never imaged with IVUS. The number of arteries that
underwent one to six IVUS exams is displayed in Table 1.
Among the arteries imaged by IVUS, 39% were LAD, 32%
were LCX, and 29% were RCA.
Stenoses frequency and severity. Regardless of severity,
stenoses were observed in 16.2% (21/130) of nonimaged
arteries and 19.5% (107/548) of arteries previously imaged
with IVUS (p  0.38). There was no correlation between
the frequency of stenoses and the number of previous IVUS
exams performed. The vast majority of lesions in the
IVUS-imaged arteries (98.7%) and nonimaged arteries
(98.5%) were 50% severe (p  0.82).
The stenosis severity of nonimaged and imaged arteries
was not statistically different (F7,171  1.05, p  0.4).
Comparing the subgroups of arteries that underwent one or
two versus three to six IVUS examinations, the difference in
stenosis severity between nonimaged and imaged vessels was
not significant (p  0.61 and p  0.25, respectively).
Abbreviations and Acronyms
CAD  coronary artery disease
CASS  Coronary Artery Surgery Study
IVUS  intravascular ultrasound
LAD  left anterior descending artery
LCX  left circumflex artery
QCA  quantitative coronary angiography
RCA  right coronary artery
Table 1. Number of Arteries (LAD, LCX, and RCA) That
Underwent 0 to 6 IVUS Exams
Number of
IVUS Exams LAD LCX RCA Total
0 14 48 68 130
1 57 49 43 149
2 55 50 43 148
3 43 43 33 119
4 32 19 21 72
5 18 13 13 44
6 7 4 5 16
IVUS intravascular ultrasound; LAD left anterior descending artery; LCX left
circumflex artery; RCA  right coronary artery.
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Arterial lumen diameter measurements. The arterial lu-
men diameter of nonimaged and imaged vessels was not
statistically different (F7,167  1.91, p  0.07), even after
adjusting for type of epicardial artery, CASS segment,
number of IVUS exams, and years after transplantation.
Nonimaged vessels were nonsignificantly smaller in diame-
ter than the imaged vessels. Furthermore, mixed models
statistical analysis with spatial repeated measures showed no
significant decrease in vessel lumen diameter with increasing
number of IVUS exams. Figures 1 to 3 display the mean
arterial lumen diameters for the LAD, LCX, and RCA by
arterial segments and number of IVUS exams.
QCA measurements at baseline versus follow-up coro-
nary angiograms. In a subgroup analysis of 31 patients,
matched diameter measurements were performed at base-
line and one year after two, three, or four IVUS studies.
There were a total of 33 nonimaged arteries and 60 imaged
arteries. Compared with baseline, a significant decrease in
vessel diameters was seen in follow-up angiograms in both
nonimaged and imaged vessels (Fig. 4). This decrease in
diameter, however, was not significantly different in previ-
ously imaged versus nonimaged vessels. These findings were
consistent regardless of the number of IVUS exams.
DISCUSSION
The results of our study indicate that serial IVUS examina-
tions after transplantation do not lead to accelerated vascu-
lopathy. Neither the comparison among imaged and non-
imaged vessels nor the comparison among vessels imaged
one to six times showed significant differences in vessel
Figure 1. Arterial diameter of the left anterior descending artery displayed by the Coronary Artery Surgery Study segment and the number of intravascular
ultrasound (IVUS) exams. No significant difference was found among the diameters of arteries that had no IVUS exam versus those that underwent 1 to
6 exams.
Figure 2. Arterial diameter of the left circumflex artery displayed by the Coronary Artery Surgery Study segment and the number of intravascular ultrasound
(IVUS) exams. No significant difference was found among the diameters of arteries that had no IVUS exam versus those that underwent 1 to 6 exams.
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diameters or stenoses frequency. These results are impor-
tant, because serial IVUS assessment of plaque volume has
become an end point in studies examining transplant
vasculopathy in cardiac transplant recipients and in assessing
the progression and regression of native coronary athero-
sclerosis in nontransplant patients.
As applications for repeated IVUS examinations emerge,
legitimate concerns over long-term deleterious effects of
repeated intravascular manipulation arise. Animal studies
have demonstrated that foreign body-induced endothelial
injury can lead to the development of atherosclerosis. Moore
et al. (10) demonstrated that placement of a catheter in a
rabbit aorta resulted in intimal thickening and atheroscle-
rotic plaque formation in areas of repeated wall contact. Lee
et al. (11) observed in animals various forms of arterial wall
injury resulting from instrumentation of arteries with a
fiber-optic scope. The risk of endothelial injury was associ-
ated with large diameter of the scope, rigidity of the scope,
and frequency of the interventions (11). However, human
in-vivo data examining the effect of diagnostic intravascular
catheters on intimal injury and progression of atherosclero-
sis are limited.
The type and frequency of immediate complications of
IVUS have been well described. These include vessel spasm,
dissections, and guidewire complications (12–16). However,
there is little data demonstrating the long-term safety of
repeated IVUS exams and its effect on the progression of
transplant CAD. So far, two publications have evaluated the
long-term safety of IVUS. These studies describe results
after a maximum of two previous IVUS exams. Pinto et al.
(12) evaluated CAD progression in 38 cardiac transplant
recipients one year after the initial IVUS examination. No
significant difference in vessel lumen diameter was noted
between the 49 imaged and 61 nonimaged vessels (12). Son
et al. (17) evaluated annual QCAs of 86 heart transplant
recipients over a period of two years post-transplantation.
There was no significant difference in lumen diameters
between imaged and nonimaged arteries after a maximum of
two IVUS exams in 26 patients (17).
To our knowledge, this is the largest and the longest
study evaluating the effect of repeated IVUS examinations
on vessel lumen diameter and stenosis severity as assessed by
QCA. Vessel diameter was measured in the three CASS
segments of each epicardial artery in order to account for the
diffuse nature of allograft vasculopathy. Discrete stenoses
Figure 3. Arterial diameter of the right coronary artery displayed by the Coronary Artery Surgery Study segment and the number of intravascular ultrasound
(IVUS) exams. No significant difference was found among the diameters of arteries that had no IVUS exam versus those that underwent 1 to 6 exams.
Figure 4. Baseline and follow-up quantitative coronary angiography mea-
surements (up to four years after cardiac transplantation) of proximal and
distal diameters in arteries with previous intravascular ultrasound (IVUS)
exams (n  60) and without previous IVUS exams (n  33). A significant
decrease in proximal and distal vessel diameters could be demonstrated in
the nonimaged and imaged arteries. However, the change in diameter
between baseline and follow-up exams in nonimaged as well as imaged
arteries was not statistically different (see p value). Diamond/solid line 
imaged proximal; triangle/solid line  nonimaged proximal; diamond/
dashed line  imaged distal; triangle/dashed line  nonimaged distal.
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were also evaluated in order to capture possible focal points
of injury by the IVUS catheter that could progress to
atherosclerotic lesions. We did not find any significant
difference in the vessel lumen diameters and stenosis severity
between imaged and nonimaged arteries, indicating no
deleterious effect of repeated IVUS imaging. Data analysis
revealed a statistically insignificant trend towards smaller
diameters in nonimaged vessels. This can be attributed to
the basis for selection of imaged arteries. Although our
institutional protocol advocates multivessel imaging, safety
is paramount (18). Operators have the discretion to forego
imaging any artery with a potential increased risk of com-
plication, such as smaller size, tortuous course, or unusual
takeoff.
In a subset of patients, matched analysis was performed in
which each artery (with and without IVUS exam) was
evaluated with QCA of matched angiograms at baseline and
follow-up after two, three, or four IVUS exams. There was
a significant decrease in vessel diameter from baseline to
follow-up QCA measurements in imaged as well as non-
imaged vessels. However, when the change in diameter
between baseline and follow-up was compared, no signifi-
cant difference could be found in the nonimaged or imaged
arteries. These results imply an overall progression of
transplant vasculopathy with time regardless of previous
IVUS exams. Similarly, Tsutsui et al. (19) demonstrated
progressive lumen loss by serial IVUS measurements over a
five-year period post-transplant.
Study limitations. Several limitations of our study warrant
further discussion. First, patients with advanced vasculopa-
thy did not undergo repeated IVUS examinations. There-
fore, these findings pertain to patients with less severe
disease. Second, arteries with smaller diameters were not
imaged for safety considerations, thereby possibly affecting
the lumen diameter measurements. Because our results are
based on angiographic end points, atherosclerotic changes
that do not result in luminal changes could not be analyzed.
In a subset of patients, diameter measurements were per-
formed at the same arterial site at baseline and follow-up.
The required matching results in an unblinded comparison.
However, the use of QCA should have minimized the bias
from unblinding. Furthermore, this study was limited to
cardiac transplant recipients, and, thus, the results may not
be generalizable to nontransplant patients.
Transplant CAD is the most important cause for long-
term mortality in heart transplant patients, and it is difficult
to detect by angiography or noninvasive studies. Intravas-
cular ultrasound allows early detection and monitoring of
transplant CAD. However, IVUS is not widely used be-
cause of its invasive nature and lack of convincing safety
data. Our study demonstrates that repeated IVUS imaging
for the surveillance of allograft vasculopathy appears to be
safe and does not accelerate transplant CAD. The results of
this study can be used as a reference for safety in nontrans-
plant patients who undergo serial IVUS studies until similar
data specific to this patient population are available.
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